Catalogo dei prodotti della ricerca

ASSANTO, GIOVANNI MANFREDI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 696
NA - Nord America 662
EU - Europa 536
SA - Sud America 119
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.046
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 644
IT - Italia 327
SG - Singapore 300
CN - Cina 123
HK - Hong Kong 122
BR - Brasile 92
VN - Vietnam 55
DE - Germania 50
FI - Finlandia 32
SE - Svezia 23
IN - India 22
AR - Argentina 16
GB - Regno Unito 16
BG - Bulgaria 15
NL - Olanda 14
ID - Indonesia 13
MA - Marocco 13
RU - Federazione Russa 10
FR - Francia 9
JP - Giappone 9
BD - Bangladesh 8
AT - Austria 7
CA - Canada 7
IQ - Iraq 7
MX - Messico 7
PL - Polonia 7
TR - Turchia 6
ZA - Sudafrica 6
TW - Taiwan 5
BE - Belgio 4
ES - Italia 4
LT - Lituania 4
PK - Pakistan 4
TG - Togo 4
CO - Colombia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
PH - Filippine 3
SA - Arabia Saudita 3
CL - Cile 2
EC - Ecuador 2
IE - Irlanda 2
IR - Iran 2
KE - Kenya 2
LK - Sri Lanka 2
LV - Lettonia 2
RO - Romania 2
UA - Ucraina 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AZ - Azerbaigian 1
CH - Svizzera 1
GT - Guatemala 1
IL - Israele 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
MG - Madagascar 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.046
Salva come PNG Salva come JPEG
Città #
Singapore 161
Ashburn 145
Rome 127
Hong Kong 122
Santa Clara 54
Los Angeles 32
Milan 29
Munich 25
Hillsboro 23
Beijing 22
Boardman 22
Dallas 22
Ho Chi Minh City 21
Buffalo 20
Turku 19
Chandler 17
Cosenza 17
Fairfield 16
New York 16
Redondo Beach 16
Sofia 14
Cesano Maderno 13
Clementon 13
Casablanca 12
Frankfurt am Main 11
Ann Arbor 10
São Paulo 10
Wilmington 9
Hanoi 8
Lappeenranta 8
Boston 7
Florence 7
Tokyo 7
Falkenstein 6
Fiesole 6
London 6
Pisa 6
Princeton 6
Reggio Emilia 6
Warsaw 6
Cambridge 5
Catanzaro 5
Dhaka 5
Helsinki 5
Jakarta 5
Johannesburg 5
Somerville 5
Woodbridge 5
Bengaluru 4
Bremen 4
Brooklyn 4
Chieuti 4
Columbus 4
Haiphong 4
Houston 4
Lawrence 4
Lomé 4
Nuremberg 4
Paris 4
Poplar 4
Rio de Janeiro 4
San Paolo di Civitate 4
Thái Bình 4
Baghdad 3
Curitiba 3
Da Nang 3
Hefei 3
Istanbul 3
Kansas City 3
Lucca 3
Millbury 3
Moscow 3
Motta di Livenza 3
Naples 3
Seattle 3
Toronto 3
Täby 3
Anderlecht 2
Ankara 2
Atlanta 2
Bassano del Grappa 2
Biên Hòa 2
Boydton 2
Brussels 2
Chang-hua 2
Chennai 2
Collegeville 2
Colombo 2
Delft 2
Delhi 2
Dublin 2
Elk Grove Village 2
Erbil 2
Federal 2
Formia 2
Fortaleza 2
Giza 2
Guangzhou 2
Handan 2
Kunming 2
Totale 1.285
Salva come PNG Salva come JPEG
Nome #
Incidence and outcome of severe complications in patients with paroxysmal nocturnal hemoglobinuria: A real life scenario from a single center 30 years experience 159
Whole body MRI with diffusion weighted imaging versus 18F‑fuorodeoxyglucose‑PET/CT in the staging of lymphomas 96
Lymphadenopathies before and during the pandemic COVID-19: increasing incidence of metastases from solid tumors 95
Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients? 86
Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic 86
Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study 84
High basal maximal standardized uptake value (Suvmax) in follicular lymphoma identifies patients with a low risk of long-term relapse 79
Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulants 78
Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience 71
Asciminib in chronic myeloid leukemia 60
RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort 60
Early clearance of hairy cell leukaemia in the bone marrow after first‐line treatment with cladribine predicts a favourable outcome 58
Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience (Bone Marrow Transplantation, (2021), 56, 6, (1455-1457), 10.1038/s41409-020-01174-w) 57
Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients 56
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors 56
A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD 56
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants: comparison between patients with major congenital thrombophilia versus non-thrombophilic patients 56
Hematopoietic Stem Cell Transplantation in Myelofibrosis: The Experience of Three University Transplant Centres in Rome 56
Research topic: measurable residual disease in hematologic malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies? 55
Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment 55
Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study 54
Direct oral Anticoagulants (DOACs) in the Onco-Hematologic Patients 54
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study 54
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study 53
Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up 51
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects 48
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Comment from Serrao et al 46
The impact of radiotherapy and attenuated chemotherapy regimens in older patients with classic hodgkin lymphoma. A real-life study from the ReLLi Network 45
From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia care 43
Impact of Daratumumab on Stem Cell Mobilization and Transplant in Patient with Newly Diagnosed Multiple Myeloma: A Real Word Single-Centre Study 42
Evaluation of VTE-PREDICT Risk Score in Patients Receiving Low-Dose DOACs for Venous Thromboembolism (VTE) Secondary Prophylaxis 38
EZH2 gene mutations and copy number variation as prognostic markers in advanced follicular lymphoma 36
Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma 36
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies 32
Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro‐HL multicenter study 19
null 8
null 3
Totale 2.121
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.880
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 4 6 0 3 0
2021/202283 4 3 3 2 7 9 2 8 10 8 20 7
2022/2023130 9 15 3 9 9 13 18 19 16 6 4 9
2023/2024230 12 29 8 32 20 49 8 14 1 18 12 27
2024/2025761 12 67 24 55 39 56 23 34 104 38 74 235
2025/2026877 246 115 146 196 174 0 0 0 0 0 0 0
Totale 2.121